Rani Therapeutics’ $73M IPO will fund upcoming clinical trials – TechCrunch
Rani Therapeutics, a San Jose-based company developing a pill to replace medical injections, went public on Friday. According to S-1 filings, shares were estimated to price between $14 and $16…